Sanofi Reports Q3 Earnings Beat; Raises FY22 EPS Guidance

Seeking Alpha2022-10-28

Sanofi Q3 Non-GAAP EPS of €2.88 beats by €0.22.Revenue of €12.48B (+19.7% Y/Y) beats by €440M, sales growth of 9.0% at CER driven by Specialty Care and Vaccines.Specialty Care grew 19.9% driven by ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1